M. Kannan

Diffusion MR neurography in mono neuropathies clinical MRN and EMNG correlation

R. Vadapalli, M. Kannan, M. Yerasu, 2014 .

Evaluation of a web-based fall prevention program among people with multiple sclerosis.

G. Cutter, M. Cameron, M. Kannan, 2019, Multiple sclerosis and related disorders.

Multiple Sclerosis A Review of Vascular Disease Risk Factors and Multiple Sclerosis

V. Yadav, M. Kannan, 2017 .

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Jeffrey A. Cohen, Islam M. Zaydan, Gregory F. Wu, 2022, The Lancet Neurology.

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

A. Cross, Aaron E Miller, M. Goldman, 2023, The Lancet Neurology.

Weakness in an Elderly Woman With Asthma and Chronic Sinusitis

J. Greene, M. Kannan, 2016, The Neurohospitalist.

Many Imaging Faces of Hansen's Disease on MRI and MR neurography revisited

Abhinav Sriiram Vadapalli, R. Vadapalli, K. H. Vardhana, 2015 .